1-methyltryptophan has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campa, A; Consolaro, MEL; da Costa Souza, P; Faião-Flores, F; Felipe-Silva, A; Maria-Engler, SS; Migliorini, S; Oliveira, EA; Sandri, S; Tiago, M; Vazquez, VL; Watanabe, LRM | 1 |
| Dréno, B; Khammari, A; Knol, AC; Le Naour, S; Pandolfino, MC | 1 |
2 other study(ies) available for 1-methyltryptophan and Skin Neoplasms
| Article | Year |
|---|---|
Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.
Topics: Antineoplastic Agents; Cell Line, Tumor; Databases, Genetic; Drug Resistance, Neoplasm; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma; Molecular Targeted Therapy; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Tryptophan; Vemurafenib | 2020 |
Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coculture Techniques; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphocytes, Tumor-Infiltrating; Melanoma; Skin Neoplasms; Tryptophan | 2019 |